01—Abstract
Summary
Summary of the 10-K filed March 18, 1997. Cited figures are marked; the original filing is the authoritative source.
Colgate-Palmolive's 1996 10-K shows a company in recovery and expansion mode.
Net sales rose 5% to $8,749.0 milliona on 5% volume growth, with gains in every geographic region. Earnings before interest and taxes (EBIT) grew 12% to $1,152.0 million versus $1,029.4 million in 1995 excluding the restructuring charge. Net income was $635.0 million, or $4.19 per share primary, compared with $172.0 million in 1995, which included a $369.2 million after-tax restructuring charge.
Excluding that charge, 1995 earnings were $541.2 millionb, so 1996 income grew about 17%. Gross margin improved to 49.1% from 47.9%, and the effective tax rate fell to 33.5% from 52.7% in 1995, which was distorted by the restructuring. Balance sheet and cash flow improved meaningfully.
Operating cash flow rose 13% to $917.4 millionc, funding $459.0 million of capital expenditures and $296.2 million of dividends while reducing total debt, with long-term debt falling from $3,029.0 million to $2,897.2 million. The net debt-to-total-capitalization ratio dropped to 58% from 64%. Shareholders' equity rose to $2,034.1 million from $1,679.8 million.
Management also announced a two-for-one stock split approved March 6, 1997, payable to holders as of April 25, 1997, though the financial statements in this filing are not restated for it. Key risks flagged by management include economic uncertainty in Venezuela, a slow Mexican recovery, competitive pressure and slow growth in Western Europe, and conditions attached by Brazilian antitrust authorities to the 1995 Kolynos acquisition, which require suspending the Kolynos toothpaste brand in Brazil for four years. The restructuring program, with savings expected to reach $100.0 milliond annually by 1998, is largely complete, with substantial completion expected in 1997.
02—Key points
Key Highlights
- Net sales grew 5% to $8,749.0 million in 1996, driven by 5% volume growth across all regions; Oral, Personal and Household Care sales rose 4% to $7,880.3 million and Pet Nutrition and Other rose 10% to $868.7 million.
- EBIT increased 12% to $1,152.0 million (vs. $1,029.4 million excluding 1995 restructuring); gross margin expanded to 49.1% from 47.9%.
- Net income of $635.0 million ($4.19 per share primary) versus $172.0 million in 1995, which was depressed by a $460.5 million pretax restructuring charge; excluding the charge, 1995 net income was $541.2 million.
- Operating cash flow rose 13% to $917.4 million, and net debt-to-total-capitalization improved to 58% from 64%.
- Two-for-one common stock split approved March 6, 1997 (record date April 25, 1997); per-share figures in the filing are not restated for the split, where 1996 primary EPS would be $2.09 post-split.
- Kolynos acquisition in Brazil faces antitrust conditions requiring a four-year suspension of the Kolynos toothpaste trademark and third-party toothpaste contract manufacturing.
- Restructuring program (14 of 24 targeted factories closed or reconfigured by year-end 1996) is expected to deliver $100.0 million in annual savings by 1998.
03—Questions
Frequently Asked Questions
Did Colgate's profitability really improve in 1996, or is the increase just a comparison against the 1995 restructuring charge?
Both, but the underlying improvement is real. Reported 1996 net income of $635.0 million was up sharply from $172.0 million in 1995, but the 1995 figure included a $369.2 million after-tax restructuring charge. Excluding that charge, 1995 net income was $541.2 million, so the underlying increase is about 17%. EBIT rose 12% against the adjusted 1995 base, and gross margin expanded by about 120 basis points, which points to operational gains rather than only easy comparisons.
How is the company funding its growth and shareholder returns?
Primarily through internally generated cash. Operating cash flow of $917.4 million covered $459.0 million of capital expenditures and $296.2 million of dividends, with the remainder used to reduce debt. Management states that internal cash flows are adequate for planned operations and capital spending, while significant acquisitions such as Kolynos would require external financing. Long-term debt declined to $2,897.2 million from $3,029.0 million.
What are the main risks to growth identified in the filing?
Management cites economic uncertainty and currency volatility in Venezuela, a slow recovery in Mexico, and competitive pressure and slow economic growth in Western Europe. The Kolynos acquisition in Brazil also carries risk, since antitrust-mandated undertakings could affect performance there. In addition, the change in the functional currency of Mexican operations to the U.S. dollar effective January 1997 has an effect on future results that management says cannot yet be determined.
How does the stock split affect the per-share numbers in this report?
The two-for-one stock split approved March 6, 1997 is a subsequent event and is not reflected in the financial statements of this filing. Per-share figures shown in the statements are pre-split. Note 17 provides restated per-share amounts: 1996 primary EPS of $2.09 and fully diluted EPS of $1.95, compared with the unadjusted $4.19 and $3.90. Shareholders receive one additional share for each share held as of April 25, 1997, and par value remains $1 per share.
Is the restructuring program complete, and what savings should investors expect?
The program is largely complete but not finished. Of the 24 factories targeted for closure or significant reconfiguration, 14 had been closed or reconfigured by the end of 1996, and realignments are expected to be substantially complete during 1997, mainly in North America and Europe. The remaining restructuring accrual was $203.2 million at year-end 1996. Management expects savings from the program to reach $100.0 million annually by 1998.
04—Continue